Form 4 for CBLL Ceribell, Inc.
Accepted 2024-10-16 00:00:00 ET · period of report 2024-10-11 · accession 0000950170-24-115007 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DI | 2024-10-16 | 2024-10-15 | CBLL | Tammenoms Bakker Juliet | Dir | C - Cnv Deriv | — | +2.14M | 2.24M | +2,201% | — |
| DI | 2024-10-16 | 2024-10-15 | CBLL | Tammenoms Bakker Juliet | Dir | P - Purchase | $17.00 | +237.2K | 2.48M | +11% | +$4.03M |
| D | 2024-10-16 | 2024-10-11 | CBLL | Tammenoms Bakker Juliet | Dir | A - Grant | $0.00 | +6,618 | 6,618 | New | $0 |
| DI | 2024-10-16 | 2024-10-15 | CBLL | Tammenoms Bakker Juliet | Dir | C - Cnv Deriv | $0.00 | -2.14M | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-10-15 | C | A | 2,140,600 | — | 2,237,876 | I By Longitude Venture Partners IV, L.P. | — | — | (F3) Each share of the issuer's Preferred Stock automatically converted into one (1) share of the issuer's Common Stock immediately prior to the closing of the issuer's initial public offering on October 15, 2024 and had no expiration date. (F2) The securities are held by Longitude Venture Partners IV, L.P. ("LVPIV"). Longitude Capital Partners IV, LLC ("LCPIV") is the general partner of LVPIV and may be deemed to have voting, investment, and dispositive power over the securities held by LVPIV. Juliet Tammenoms Bakker, a member of the issuer's board of directors, and Patrick G. Enright are managing members of LCPIV and may each be deemed to share voting, investment, and dispositive power over the securities held by LVPIV. Each of LCPIV, Ms. Tammenoms Bakker, and Mr. Enright disclaims beneficial ownership of such securities except to the extent of the respective pecuniary interests therein. |
| 2 | Common | Common Stock | 2024-10-15 | P | A | 237,234 | $17.00 | 2,475,110 | I | — | — | |
| 3 | Common | Common Stock | 2024-10-11 | A | A | 6,618 | $0.00 | 6,618 | D By Longitude Venture Partners IV, L.P. | — | — | (F1) Represents 6,618 restricted stock units. (F2) The securities are held by Longitude Venture Partners IV, L.P. ("LVPIV"). Longitude Capital Partners IV, LLC ("LCPIV") is the general partner of LVPIV and may be deemed to have voting, investment, and dispositive power over the securities held by LVPIV. Juliet Tammenoms Bakker, a member of the issuer's board of directors, and Patrick G. Enright are managing members of LCPIV and may each be deemed to share voting, investment, and dispositive power over the securities held by LVPIV. Each of LCPIV, Ms. Tammenoms Bakker, and Mr. Enright disclaims beneficial ownership of such securities except to the extent of the respective pecuniary interests therein. |
| 4 | Derivative | Series C-1 Preferred Stock | 2024-10-15 | C | D | 2,140,600 | $0.00 | 0 | I By Longitude Venture Partners IV, L.P. | — · — to — | 2,140,600 Common Stock | (F2) The securities are held by Longitude Venture Partners IV, L.P. ("LVPIV"). Longitude Capital Partners IV, LLC ("LCPIV") is the general partner of LVPIV and may be deemed to have voting, investment, and dispositive power over the securities held by LVPIV. Juliet Tammenoms Bakker, a member of the issuer's board of directors, and Patrick G. Enright are managing members of LCPIV and may each be deemed to share voting, investment, and dispositive power over the securities held by LVPIV. Each of LCPIV, Ms. Tammenoms Bakker, and Mr. Enright disclaims beneficial ownership of such securities except to the extent of the respective pecuniary interests therein. (F3) Each share of the issuer's Preferred Stock automatically converted into one (1) share of the issuer's Common Stock immediately prior to the closing of the issuer's initial public offering on October 15, 2024 and had no expiration date. |